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Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in blood-
stream infections (BSIs). The purpose of this study was to evaluate the time to positivity (TTP) of blood
cultures in patients with Staphylococcus aureus BSIs and to assess its impact on clinical outcome. We performed
a historical cohort study with 91 adult patients with S. aureus BSIs. TTP was defined as the time between the
start of incubation and the time that the automated alert signal indicating growth in the culture bottle sounded.
Patients with BSIs and TTPs of culture of <12 h (n  44) and >12 h (n  47) were compared. Septic shock
occurred in 13.6% of patients with TTPs of <12 h and in 8.5% of patients with TTP of >12 h (P  0.51). A
central venous catheter source was more common with a BSI TTP of <12 h (P  0.010). Univariate analysis
revealed that a Charlson score of >3, the failure of at least one organ (respiratory, cardiovascular, renal,
hematologic, or hepatic), infection with methicillin-resistant S. aureus, and TTPs of<12 h were associated with
death. Age, gender, an APACHE II score of >20 at BSI onset, inadequate empirical antibiotic therapy,
hospital-acquired bacteremia, and endocarditis were not associated with mortality. Multivariate analysis
revealed that independent predictors of hospital mortality were a Charlson score of>3 (odds ratio [OR], 14.4;
95% confidence interval [CI], 2.24 to 92.55), infection with methicillin-resistant S. aureus (OR, 9.3; 95% CI, 1.45
to 59.23), and TTPs of <12 h (OR, 6.9; 95% CI, 1.07 to 44.66). In this historical cohort study of BSIs due to
S. aureus, a TTP of <12 h was a predictor of the clinical outcome.
The evaluation for bloodstream infection (BSI) is an impor-
tant step in the workup of febrile patients (24). The majority of
positive blood cultures are associated with true bloodstream
infections (10), and a positive blood culture is frequently the
trigger for the initiation of antimicrobial therapy (24).
Staphylococcus aureus is a highly common cause of BSIs
(27). Moreover, mortality increases when inadequate empir-
ical antibiotic therapy is given to patients with BSIs due to
S. aureus (12). The rapid detection of a BSI has an impact on
the length of hospitalization (2) and the mortality of bacte-
remic patients (4).
Physicians often make clinical predictions about individual
patients (13). However, few studies have formally assessed the
bacterial load (9), as indirectly measured as the time to posi-
tivity (TTP) of blood cultures, as a predictor of clinical out-
come (14, 23).
The purpose of this study was to evaluate the association
between the time to positivity of blood cultures in patients with
S. aureus BSIs and the clinical outcome.
MATERIALS AND METHODS
Setting. The Virginia Commonwealth University Medical Center (VCUMC) is
an 820-bed tertiary-care facility in Richmond, Virginia. The hospital houses nine
intensive care units (ICUs), including pediatric ICUs and a burn unit. Approx-
imately 30,000 patients are admitted annually.
Study design. Patients with BSIs at VCUMC from 15 December 2003 through
31 December 2004 were identified retrospectively by use of the electronic med-
ical microbiology record. For each case, the time to blood culture positivity was
retrieved from the hospital’s automated blood culture instrument. The medical
microbiology record identified the patient by medical record number so that a
retrospective chart review could be conducted. Patients were considered to have
had a BSI due to S. aureus if one or more blood cultures were positive for this
organism. Each patient was included only once, at the time of the first BSI.
Patients less than 18 years old, those with polymicrobial infections, and those
receiving antimicrobial therapy at the time of the BSI were excluded from the
analysis.
Data collected included age; gender; location of the patient (ward versus
ICU); the duration of hospitalization prior to the onset of the BSI; the presence
of predisposing clinical factors, including neutropenia (defined as an absolute
neutrophil count of 500/l); the use of peritoneal dialysis or hemodialysis; and
the presence of central venous catheters. The sources of secondary BSIs were
identified by cultures of samples obtained from the primary site of infection that
yielded the same pathogen. Adverse outcomes (organ failure and in-hospital
mortality) occurring during the course of hospitalization were recorded.
The severity of the underlying disease preceding the positive blood culture was
classified by use of the Charlson weighted comorbidity index (6) and the McCabe
classification (19). The patient’s physiological condition on the day of the BSI
was assessed by using the APACHE II score (15). At the onset of the BSI, the
clinical condition of each patient was classified as systemic inflammatory re-
sponse syndrome (SIRS), sepsis, severe sepsis, or septic shock by using criteria
previously published by the American College of Chest Physicians/Society of
Critical Care Medicine (1). SIRS was defined as two or more of the following: (i)
a temperature of 38°C or 36°C, (ii) a heart rate of 90 beats per minute, (iii)
a respiratory rate of 20 breaths per minute or a partial arterial CO2 pressure
of 32 mm Hg, or (iv) a white blood cell count of 12 109/liter or 4 109/liter
or the presence of more than 10% immature neutrophils.
Severe sepsis was defined as organ dysfunction, hypotension, or systemic
manifestations of hypoperfusion. Septic shock was defined as sepsis associated
with hypotension unresponsive to intravenous fluid challenge or the need for
treatment with a vasopressor agent. The maximal inflammatory response was
defined as severe sepsis, septic shock, or death. The presence of organ system
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failure at the time of the BSI and during the clinical course was assessed by using
the criteria described by Fagon et al. (7). Nosocomial infection was defined as an
infection that occurred48 h after hospital admission, an infection that occurred
48 h after admission to the hospital for patients who had been hospitalized in
the 3 weeks prior to the admission, or an infection that occurred 48 h after
admission to the hospital for patients who had been transferred from another
hospital or nursing home (8). The sources of infection were also defined accord-
ing to Centers for Disease Control and Prevention criteria (8). Endocarditis was
diagnosed by means of the modified Duke criteria (18). Time to positivity was
defined as the time between the start of incubation and the time to sounding of
the alert signal on the automated blood culture instrument. Adequate empirical
antimicrobial treatment was defined as therapy that was administered within 24 h
after samples for blood culture were obtained and that included any antimicro-
bial agent to which the S. aureus isolate was susceptible.
Microbiological methods. Blood cultures were processed by the institution’s clin-
ical laboratory using the BacT/ALERT blood culture instrument (bioMe´rieux,
Durham, NC). Each blood culture set consisted of an FA aerobic bottle and an
SN anaerobic bottle. All the samples of blood cultures were collected and
submitted in a timely manner to the microbiology laboratory. All the bottles were
loaded into the instrument at any time of the day (24 h a day, 7 days a week)
without delay. The time to positivity of the first bottle in a set to be flagged as
positive was used to determine the time to positivity and was obtained by using
the system’s software.
Statistical analysis. Continuous variables were compared by using the Student
t test for normally distributed variables and the Mann-Whitney U test for non-
normally distributed variables. Differences in proportions were compared by a
chi-square test or Fisher’s exact test, when appropriate. Mean values 1 stan-
dard deviation were reported. Alpha was set equal to 0.05, and all tests of
significance were two tailed. When collinearity was identified between two vari-
ables in a correlation matrix, the one with the greatest clinical relevance associ-
ated with mortality was included in the multivariate analysis. Odds ratios (ORs)
with 95% confidence intervals (CIs) were calculated for all variables. Variables
found to be significant by univariate analysis were then entered into a multivar-
iate model. All statistical analyses were done by using the Statistical Package for
the Social Sciences software (SPSS, Inc., Chicago, IL).
RESULTS
Study population and patient characteristics. A total of 373
patients with clinically significant episodes of BSIs were iden-
tified at VCUMC during the 1-year study period. Of these, 294
patients (78.8%) had bacterial BSIs and 79 (21.2%) had fungal
BSIs. A total of 113 patients (30.3%) with S. aureus BSIs were
identified. Of these 113 patients, 18 patients were excluded
because they were on antimicrobial therapy when blood sam-
ples for culture were obtained and 4 patients were excluded
because they had polymicrobial BSIs. Only the remaining 91
patients were analyzed.
The mean age was 50  15 years (range, 20 to 86 years).
Twenty-four patients (26.4%) were over 60 years of age. The
most frequent diagnoses responsible for hospitalization were
infection (cellulitis, septic arthritis, and endocarditis) (31.9%),
renal failure (19.8%), gastrointestinal diseases (15.4%), and
solid and hematologic malignancies (13.2%). The most fre-
quent sources of BSIs were central venous catheters (26.4%)
and skin and soft tissues (13.2%). The average duration of
hospitalization was 18  14.8 days (range, 3 to 78 days). Most
BSIs (63.7%) occurred during the first 48 h of hospitalization.
Thirteen cases had been hospitalized less than 3 weeks previ-
ously (Table 1).
Time to positivity. The median time to positivity was 12.2 h.
Because previous studies reported that the growth of S. aureus
from endovascular sources within 14 h correlated with compli-
cations, we divided our study into two groups: patients with an
early time to positivity (TTP of 12 h) and patients with a late
time to positivity (TTP of 12 h). Associated risk factors and
outcomes of the two TTP groups are summarized in Table 2.
There were significant differences in age (P  0.027) but not
gender (P  0.078) between the two groups. No statistically
significant differences in the proportion of patients with end-
stage renal disease, diabetes mellitus, or underlying malig-
nancy were observed between the two TTP groups (P  0.05).
Endocarditis was more commonly associated with a BSI TTP
of 12 h than with a BSI TTP of 12 h (25.0% and 8.5%,
respectively; P  0.048). Patients with early positive cultures
were more likely to have more severe underlying disease
(52.3% of patients with early positive cultures had a Charlson
score of 3, whereas 29.8% of patients with late positive cul-
tures had a Charlson score of 3; P  0.029). All neutropenic
patients (five cases) had TTPs12 h (100.0%). Central venous
catheters were also more commonly associated with a BSI TTP
of 12 h than with a BSI TTP of 12 h (38.6% and 14.9%,
respectively; P  0.010). There were no differences in the
nonintravascular catheter sources of BSIs between the two
groups (P  0.05). No statistically significant differences in the
proportion of methicillin resistance in the S. aureus isolates
between the two groups were observed (50.0% in the group
with a TTP of 12 h and 42.6% in the group with a TTP of
12 h; P  0.48).
TABLE 1. Demographic characteristics of 91 adult patients with
monomicrobial S. aureus BSIs
Variable No. of patients % of patients
Gender
Male 50 54.9
Female 41 45.1
Age (yr)
60 67 73.6
60 24 26.4
Diagnosis on admission
Infection (cellulitis, septic arthritis,
endocarditis)
29 31.9
Renal failure 18 19.8
Gastrointestinal disease 14 15.4
Neoplasm 12 14.2
Trauma 7 7.7
Cardiovascular disease 5 5.5
Respiratory disease 3 3.3
Neurologic disease 3 3.3
Site of infection
Intravascular catheter 24 26.4
Skin and soft tissue 12 13.2
Bone and joint 7 7.7
Respiratory 6 6.6
Wound 5 5.5
Abdominal 3 3.3
Urinary tract 2 2.2
Other 9 9.9
Unknown 23 25.3
Hospital stay (days) prior to BSI
2a 66 72.5
3–7 17 18.7
8–14 7 7.7
15 1 1.1
a Eight cases were considered hospital acquired (includes patients with hospi-
talization in the previous 3 weeks).
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Clinical course. Septic shock occurred in 13.6% of the group
with a TTP of 12 h and in 8.5% of the group with a TTP of
12 h (P  0.22). No statistically significant differences were
observed in maximal SIRS (severe sepsis, septic shock, or
death) between the two groups (20.5% in the group with a TTP
of 12 h and 14.9% in the group with a TTP of 12 h; P 
0.59). Patients with a TTP of 12 h were significantly more
likely to have an APACHE II score of 20 at BSI onset (39%
versus 10.6% for the group with a TTP of 12 h; P  0.010).
No difference in hospital-acquired bacteremia was observed
between the two groups (31.8% for the group with a TTP of
12 h versus 40.4% for the group with a TTP of 12 h; P 
0.39). Appropriate empirical antimicrobial use was docu-
mented in greater than 79.5% of the group with a TTP of12 h;
however, this was not statistically significant (79.5% in the
group with a TTP of 12 h versus 61.7% in the group with a
TTP of 12 h; P  0.063). Patients with BSIs caused by
methicillin-resistant S. aureus (MRSA) strains were more
likely to have received inadequate empirical antimicrobial
therapy (70.4% in MRSA-infected patients versus 29.6% in
non-MRSA-infected patients; P  0.003).
Hematologic failure was more commonly seen in the group
with a TTP of 12 h (15.9% versus 2.1% for the group with a
TTP of 12 h; P  0.027). No significant differences in the
incidence of respiratory, renal, and hepatic failures were noted
between the two groups. The overall crude mortality was
14.3% (13 of 91 patients). In-hospital mortality was greater in
the group with a TTP of 12 h than in the group with a TTP
of 12 h TTP (25.0% and 4.3%, respectively; P  0.006).
Univariate analysis revealed that a Charlson score of 3,
the development of at least one organ system failure (respi-
ratory, cardiovascular, renal, hematologic, or hepatic), in-
fection with methicillin-resistant S. aureus, and time to pos-
itivity of 12 h were associated with death (Table 3). Age,
gender, an APACHE II score 20 at BSI onset, inadequate
empirical antibiotic therapy, hospital-acquired bacteremia,
and endocarditis were not significant predictors of mortality
on univariate analysis. By using logistic regression analysis,
TABLE 2. Risk factors for and outcomes associated with time to positivity (12 or 12 h) in S. aureus BSIs
Variable
Time to positivity 12 h (n  44) Time to positivity 12 h (n  47)
P
No. of patients % of patients No. of patients % of patients
Demographic characteristicsa 0.027
Female 24 54.5 30 63.8 0.078
ICU stay 4 9.1 7 14.9 0.52
Underlying conditions
Charlson score 3 23 52.3 14 29.8 0.029
Rapidly fatal disease (MacCabe classification) 8 18.2 3 6.4 0.11
End-stage renal disease 9 20.5 7 14.9 0.59
Diabetes 16 36.4 14 29.8 0.50
Neoplasia 7 15.9 3 6.4 0.19
Neutropenia 5 11.4 0 0.023
Endocarditis 11 25.0 4 8.5 0.048
Conditions related to the clinical course
Maximal inflammatory response 9 20.5 7 14.9 0.59
APACHE II score 20 at BSI onset 15 34.1 5 10.6 0.010
Hospital-acquired bacteremia 14 31.8 19 40.4 0.39
Methicillin-resistant S. aureus 22 50.0 20 42.6 0.48
Adequate antibiotic therapy 35 79.5 29 61.7 0.063
Source of infection
Intravascular catheter 17 38.6 7 14.9 0.010
Respiratory tract 1 2.3 5 10.6 0.20
Urinary tract 0 0.0 2 4.3 0.49
Skin and soft tissue 5 11.4 7 14.9 0.76
Bone and joint 4 9.1 3 6.4 0.71
Gastrointestinal 0 0.0 3 6.4 0.24
Wound 2 4.5 3 6.4 1.0
Other 5 11.4 5 10.6 1.0
Unknown 10 22.7 13 27.7 0.59
Outcomes
Organ failure 16 36.4 15 31.9 0.66
Septic shock 6 13.6 4 8.5 0.51
Respiratory failure 7 15.9 10 21.3 0.60
Renal failure 3 6.8 6 12.8 0.49
Hematologic failure 7 15.9 1 2.1 0.027
Hepatic failure 3 6.8 5 10.6 0.72
In-hospital mortality 11 25.0 2 4.3 0.006
a The mean ages of the patients in the groups with TTPs of 12 h and 12 h were 53.5  14.9 and 46.3  15.5 years, respectively.
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the following variables were found to be independent predic-
tors of death (Table 3): Charlson score of 3 (OR, 14.4; 95%
CI, 2.24 to 92.55), infection with methicillin-resistant S. aureus
(OR, 9.3; 95% CI, 1.45 to 59.23), and a TTP of12 h (OR, 6.9;
95% CI, 1.07 to 44.66).
DISCUSSION
We studied the association of clinical outcome and time to
positivity of blood cultures for S. aureus BSIs. Unlike prior
studies, we did not investigate the utility of blood culture TTP
as a diagnostic tool for catheter-related or endovascular S.
aureus BSIs (5, 26).
During the study period, nearly half of the patients with S.
aureus BSIs exhibited an early TTP of the blood culture
(TTP  12 h). These cases were associated with a sevenfold
higher rate of mortality than those with TTPs later than
12 h. Prior studies have shown that the growth of S. aureus
from endovascular sources within 14 h can predict compli-
cations and can possibly predict mortality (14). We found
similar results; however, our investigation also controlled
for other variables that could explain the rapid bacterial
growth, such as underlying conditions (diabetes mellitus,
neoplasia, end-stage renal disease), source of infection (in-
travascular catheter), and the severity of the patients’ con-
ditions related to the clinical course (APACHE II score and
maximal inflammatory response).
Of interest, no differences in the inflammatory responses
were observed between the two TTP groups. Additionally, no
differences in blood culture TTP were observed in patients
with diabetes mellitus, neoplasia, or end-stage renal disease.
Prompt adequate antimicrobial therapy in the group with a
TTP of 12 h may have favorably altered the outcomes in
these patients (12).
A statistically significant difference in APACHE II scores
was noted between the two TTP comparison groups at the
onset of the S. aureus BSIs. A previous study by Khatib et al.
showed that patients with early times to positivity were more
acutely ill and subsequently developed greater clinical compli-
cations (14). However, that study did not control for the se-
verity of the underlying illnesses. In our study, the Charlson
weighted comorbidity index and serial APACHE II scores
were used to assess the severities of the patients’ illnesses. The
impact of underlying disease, as measured by the Charlson
weighted comorbidity index, in patients with BSIs due to S.
aureus was reported previously (16). Although in our study the
APACHE II score was not a predictor of mortality in patients
with S. aureus BSIs, other authors have had different results
(22, 28). Thus, after controlling for the severity of illness, an
early time to positivity of the blood culture was associated with
increased mortality.
By multivariate analysis we could demonstrate that patients
who acquired a strain of methicillin-resistant S. aureus had a
high mortality rate related to the BSI. Although previous stud-
ies (11, 17, 28) have reported no increase in the mortality rate
from infections caused by resistant microorganisms, other
studies have shown the opposite (20, 21, 25). Although our
observations show that infection with methicillin-resistant S.
aureus is a predictor for mortality in patients with BSIs, the
importance of virulence factors and pathogenesis remains un-
clear. As well, the restricted therapeutic options available for
the treatment of MRSA BSIs could explain the differences in
mortality between patients with methicillin-susceptible and -re-
sistant S. aureus bacteremia (3, 20). Patients with MRSA BSIs
were more likely to have received inadequate empirical anti-
microbial therapy (70.4% in MRSA-infected patients versus
29.6% in non-MRSA-infected patients; P  0.003).
Our study is limited by the retrospective nature of our anal-
ysis. In addition, because of the relatively small sample size of
our study (n  91), a type II error could have occurred, which
would limit the ability to detect a statistically significant differ-
ence in SIRS or organ failure as predictors of mortality.
In conclusion, among adult patients with monomicrobial S.
aureus BSIs, almost one-half of the cases had a time to blood
culture positivity of 12 h. An early TTP is associated with a
significantly greater risk for mortality. TTP data are easily
obtainable in hospitals where microbiology laboratories use
automated blood culture detection methods. These data can
assist clinicians with choosing the appropriate antimicrobial
therapy as soon as possible and provide prognostic information
for patients with S. aureus BSIs.
TABLE 3. Risk factors for hospital mortality in patients with S. aureus BSIs
Variable
Death (n  13) Recovery (n  78) Univariate analysis Multivariate analysis
No. of patients % of patients No. of patients % of patients OR 95% CI OR 95% CI
Age 60 yr 5 38.5 19 24.4 1.9 0.57–6.65
Female gender 9 69.2 32 41.0 3.2 0.92–11.42
APACHE II score 20 at BSI onset 5 38.5 15 19.3 2.6 0.75–9.17
Organ failure (at least one) 9 69.2 22 28.2 5.7 1.60–20.53 4.0 0.80–20.31
Respiratory failure 5 38.5 12 15.4 3.4 0.96–12.31
Cardiovascular failure 4 30.8 6 7.7 5.3 1.26–22.57
Renal failure 2 15.4 7 9.0 1.8 0.34–10.04
Hematologic failure 5 38.5 3 3.8 15.6 3.13–77.88
Hepatic failure 2 15.4 6 7.7 2.2 0.39–12.20
Inadequate antibiotic therapy 6 46.2 21 26.9 2.3 0.70–7.75
Charlson score 3 11 84.6 26 33.3 11.0 2.27–53.3 14.4 2.24–92.55
Hospital-acquired bacteremia 6 46.2 27 34.6 1.6 0.49–5.30
Endocarditis 2 15.4 13 16.7 0.9 0.18–4.59
Methicillin-resistant S. aureus 11 84.6 31 39.7 8.3 1.73–40.22 9.3 1.45–59.23
Time to positivity 12 h 11 84.6 33 42.3 7.5 1.56–36.13 6.9 1.07–44.66
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